Editors

Nina Marano trained in veterinary medicine at the University of Georgia and in public health at Emory University. She is board certified by the American College of Veterinary Preventive Medicine. Since 1998 Dr. Marano has been a medical epidemiologist at CDC, first with the Foodborne and Diarrheal Diseases Branch working on antimicrobial resistance, and then with the Meningitis and Special Pathogens Branch as the principal investigator for the Anthrax Vaccine Research Program. From 2004-2006, to help CDC better respond to zoonotic disease outbreaks, Dr Marano served as CDC's veterinary public health liaison to forge new partnerships with the veterinary medical community, resulting in collaborations with the World Organization for Animal Health, the National Wildlife Health Center and the development of a CDC-sponsored research program on influenza at the human-animal interface. In June 2006, she joined the Division of Global Migration and Quarantine, first as the Branch Chief for the Travelers' Health and Animal Importation Branch and in July 2009 became the Branch Chief for the Quarantine and Border Health Services Branch. Her interests include the impact of globalization on the translocation of infectious diseases across international borders.

Martin Meltzer is senior health economist and distinguished consultant, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). His research interests include cost-benefit and cost-effectiveness analyses of health interventions and policy guidelines for use of health technologies, such as vaccines. Much of his work is multidisciplinary and has included modeling of potential responses to smallpox as a bioterrorist weapon; evaluating the cost effectiveness of Lyme disease and hepatitis A vaccination; assessing the economic impact of infectious diseases, from pandemic influenza to dengue; and modeling of raccoon rabies control by oral vaccine. He is involvement in the response to the 2009 influenza pandemic included providing frequent updates of estimates of impact of the pandemic and estimating the effectiveness of a number of different interventions. Dr. Meltzer has published more than 100 publications and has received many honors and awards, among them, CDC's Charles C. Shepard award and the James H. Nakano citation.

David Morens, medical historian and professor, University of Hawaii School of Medicine, since 1982, took academic leave of absence in 1999 to work at the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland. Dr. Morens' research interests include viral disease pathogenesis, epidemiology, and the relationship between biomedical research and public health.

Director, Emerging Pathogens Institute
Professor of Medicine (Infectious Diseases)
University of Florida College of Medicine
Dr. Morris is Director of the Emerging Pathogens Institute (EPI) at the University of Florida, Gainesville, where he is also a Professor of Medicine specializing in Infectious Diseases. He received his MD and a master's degree in public health and tropical medicine from Tulane; his residency training was at University of Texas Southwestern (Dallas) and Emory University, with service as an Epidemic Intelligence Service officer at the Centers for Disease Control and Prevention in Atlanta. He is board certified in internal medicine and infectious diseases. From 2000–2007 he served as Chairman of the Department of Epidemiology and Preventive Medicine at the University of Maryland, Baltimore (UMB) School of Medicine, and from 2005–2007 was interim dean of the UMB School of Public Health. Dr. Morris has authored over 60 textbook chapters and symposium proceedings and over 200 articles in peer-reviewed journals. He has had continuous federal grant funding since 1984; his scholarly contributions were recognized by election to the American Society for Clinical Investigation in 1996. In 2005, he was awarded the James D. Bruce Memorial Award by the American College of Physicians for Distinguished Contributions in Preventive Medicine, in recognition of his work in food safety. He has served on five National Academy of Sciences expert committees dealing with food safety, and currently serves on the Institute of Medicine's Food and Nutrition Board. He maintains an active research program in emerging pathogens and enteric diseases.

Patrice Nordmann is Professor of Medical Microbiology at the South-Paris Medical School, South Paris University, Chief of the Department of Microbiology at the hospital Bicêtre and Head of the INSERM research unit 914 Emerging Resistance to Antibiotics K. Bicêtre, Paris, France. Patrice Nordmann's interests include genetics, biochemistry, and epidemiology of emerging resistance to antibiotics, mostly in Gram negative organisms. He serves on many international committees and review panels and is on the editorial board of several journals including Antimicrobial Agents and Chemotherapy.

Didier Raoult is a professor in microbiology in Marseille Medical School and the director of the Research Unit in Infectious and Tropical Emerging Diseases (URMITE) which is associated with Aix-Marseille University, French National Center for Scientific Research (CNRS) and French Institute of Research and Development (IRD). He is also the director of the National Reference Center on intracellular bacteria such as Rickettsia, Coxiella, Bartonella, and Tropheryma whipplei. He has published more than 1,400 publications (h-index: 79). He was president of the Université de la Méditerranée and advisor to the French Ministry of Health on infectious diseases and bioterrorism. He has managed with his team the discovery or the additional description of more than 90 pathogenic bacteria for humans, as well as the discovery of the largest viruses known in the world. He has also cultured T. whipplei and highlighted that the Whipple's disease bacterium was actually a common cause of gastroenteritis in the child. His research interests include microbiogenomic, probiotics and paleomicrobiology. He has received the INSERM Grand Award in 2010.

Pierre Rollin started his career at the Pasteur Institute, Paris, working on rabies and viral hemorrhagic fevers in conjunction with overseas Pasteur Institutes. After serving a National Research Council fellowship at the US Army Medical Research Institute of Infectious Diseases, he joined the Special Pathogens Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention. He was directly involved in the discovery and characterization of a number of new and emerging diseases (such as Ebola hemorrhagic fever, Lassa fever, Marburg hemorrhagic fever, Sabia virus infection, hantavirus pulmonary syndrome, Rift Valley fever, Crimean-Congo hemorrhagic fever, Nipah encephalitis, and most recently severe acute respiratory syndrome), their diagnosis in the laboratory and development of serologic tests, the management of outbreaks in the field (public health response, patient management, safety, diagnosis in the field, epidemiology, reservoir search), and the pathogenesis of disease in human and animal models. His research interests concern emerging zoonotic and arthropod borne infectious diseases with emphasis on public health response and prepardness.

Frank Sorvillo is Professor In-Residence in the Department of Epidemiology at UCLA's School of Public Health and Acting Director of the Office of Health Assessment and Epidemiology in the Department of Public Health, Los Angeles County. He also holds an appointment as Professor of Health Sciences at Trident University. His interests include the epidemiology and control of infectious diseases, particularly parasitic agents, and the application of epidemiologic methods to the study of infectious disease problems. His current research focuses on the pubic health impact of cysticercosis and trichomoniasis.

David Walker is head of the Center for Biodefense and Emerging Infectious Diseases, Professor and Chairman of the Department of Pathology, and Carmage and Martha Walls Distinguished University Chair in Tropical Diseases at the University of Texas Medical Branch at Galveston. He began his scientific career at the Centers for Disease Control and Prevention, where he investigated Lassa fever pathogenesis in the original biosafety level 4 laboratory. While on the University of North Carolina faculty, he became an established National Institutes of Health–funded investigator of rickettsioses, conducted clinical studies of Rocky Mountain spotted fever, and initiated a lifelong commitment as an educator. In the past two decades, he has pursued the study of ehrlichioses, participating in the discovery of human infections with Anaplasma phagocytophilum. He has devoted particular effort to technology transfer and clinical and epidemiologic investigations in China, Sicily, Mexico, Brazil, Peru, and Cameroon. In 1992, he elucidated the inhalational route of infection of 41 autopsied cases of anthrax in the 1979 Sverdlovsk event and continues to analyze pathology and causes of death in these cases. He is Principal Investigator of the NIH Western Regional Center of Excellence in Biodefense and Emerging Infectious Diseases, a $105 million grant for the period 2003–2014. His research program focuses on mechanisms of immunity in animal models of rickettsioses, monocytotropic ehrlichioses, and scrub typhus.

Joseph McDade, founding editor of Emerging Infectious Diseases spent most of his career at the Centers for Disease Control and Prevention (CDC), as research microbiologist and eventually as deputy director, National Center for Infectious Diseases. Author of more than 100 scientific articles, Dr. McDade is best known for isolating and identifying Legionella pneumophila, the bacterium that causes Legionnaires' disease; for identifying the cause of ehrlichiosis, an emerging tickborne illness; and for directing research on Rocky Mountain spotted fever, Q fever, and typhus.